First disease-modifying therapy to delay the onset of type 1 diabetes recommended for NHS use
30 Jun 2026
The NICE final draft guidance on Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes, on which the BSPED was a consultee, has been released.
Read the Guidance and more here